Clinical Trial Update: Pamiparib for Consolidation Treatment of Unprogressed LS-SCLC After Concurrent Chemoradiotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating pamiparib as consolidation therapy after concurrent chemoradiotherapy in limited-stage small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limited-stage Small Cell Lung Cancer

Drugs mentioned

• Pamiparib (pamiparib)

Snippet

Sponsor: Fudan University | Conditions: Limited Stage Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN